Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Neoplasms of the CNS

  Free Subscription


16.09.2019

1 Acta Neuropathol
1 AJNR Am J Neuroradiol
1 Am J Clin Oncol
2 BMC Cancer
5 Cancer
2 Clin Cancer Res
3 J Clin Oncol
1 J Natl Cancer Inst
4 J Neurooncol
1 J Neuropathol Exp Neurol
1 J Nucl Med
12 Neuro Oncol
7 Neurosurgery
1 PLoS Genet
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. SLOAN EA, Cooney T, Oberheim Bush NA, Buerki R, et al
    Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas.
    Acta Neuropathol. 2019 Sep 12. pii: 10.1007/s00401-019-02072.
    PubMed     Text format    


    AJNR Am J Neuroradiol

  2. IV M, Liu X, Lavezo J, Gentles AJ, et al
    Perfusion MRI-Based Fractional Tumor Burden Differentiates between Tumor and Treatment Effect in Recurrent Glioblastomas and Informs Clinical Decision-Making.
    AJNR Am J Neuroradiol. 2019 Sep 12. pii: ajnr.A6211. doi: 10.3174/ajnr.A6211.
    PubMed     Text format     Abstract available


    Am J Clin Oncol

  3. GUO X, Zhang M, Li Q, Zhao J, et al
    Evaluation of Genetic Variants in MIR3142HG in Susceptibility to and Prognosis of Glioma.
    Am J Clin Oncol. 2019 Sep 10. doi: 10.1097/COC.0000000000000587.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. JIANG Q, Xie Q, Hu C, Yang Z, et al
    Glioma malignancy is linked to interdependent and inverse AMOG and L1 adhesion molecule expression.
    BMC Cancer. 2019;19:911.
    PubMed     Text format     Abstract available

  5. JANIK K, Treda C, Wlodarczyk A, Peciak J, et al
    A way to understand idiopathic senescence and apoptosis in primary glioblastoma cells - possible approaches to circumvent these phenomena.
    BMC Cancer. 2019;19:923.
    PubMed     Text format     Abstract available


    Cancer

  6. LEHRER S, Rheinstein PH, Rosenzweig KE
    Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.
    Cancer. 2018 Mar 15. doi: 10.1002/cncr.31262.
    PubMed     Text format    

  7. SLOOT S, Chen YA, Zhao X, Weber JL, et al
    Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.
    Cancer. 2018 Mar 15. doi: 10.1002/cncr.31261.
    PubMed     Text format    

  8. PRINTZ C
    Some elderly survivors of 3 common cancers have an increased risk of brain metastases.
    Cancer. 2019;125:3286-3287.
    PubMed     Text format    

  9. UEMURA MI, French JT, Hess KR, Liu D, et al
    Development of CNS metastases and survival in patients with inflammatory breast cancer.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31336.
    PubMed     Text format     Abstract available

  10. YEH TC, Liang DC, Hou JY, Jaing TH, et al
    Treatment of childhood acute lymphoblastic leukemia with delayed first intrathecal therapy and omission of prophylactic cranial irradiation: Results of the TPOG-ALL-2002 study.
    Cancer. 2018 Oct 10. doi: 10.1002/cncr.31758.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  11. CHAUVIN C, Joalland N, Perroteau J, Jarry U, et al
    NKG2D controls natural reactivity of Vgamma9Vdelta2 T lymphocytes against mesenchymal glioblastoma cells.
    Clin Cancer Res. 2019 Sep 10. pii: 1078-0432.CCR-19-0375.
    PubMed     Text format     Abstract available

  12. JUTHANI R, Madajewski B, Yoo B, Zhang L, et al
    Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model.
    Clin Cancer Res. 2019 Sep 12. pii: 1078-0432.CCR-19-1834.
    PubMed     Text format     Abstract available


    J Clin Oncol

  13. WU YL, Ahn MJ, Garassino MC, Han JY, et al
    CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3).
    J Clin Oncol. 2018 Jul 30:JCO2018779363. doi: 10.1200/JCO.2018.77.9363.
    PubMed     Text format     Abstract available

  14. BITTERMAN DS, MacDonald SM, Yock TI, Tarbell NJ, et al
    Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma.
    J Clin Oncol. 2019 Sep 9:JCO1901270. doi: 10.1200/JCO.19.01270.
    PubMed     Text format    

  15. ZWEIG JR, Neal JW
    Infiltrating the Blood-Brain Barrier in ALK-Positive Lung Cancer.
    J Clin Oncol. 2018 Jun 25:JCO2018788554. doi: 10.1200/JCO.2018.78.8554.
    PubMed     Text format    


    J Natl Cancer Inst

  16. ANDREOU T, Rippaus N, Wronski K, Williams J, et al
    Hematopoietic stem cell gene therapy for brain metastases using myeloid cell-specific gene promoters.
    J Natl Cancer Inst. 2019 Sep 10. pii: 5566500. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Neurooncol

  17. VILLANI V, Pace A, Vidiri A, Tanzilli A, et al
    Correction to: Phase II study of weekly carboplatin in pretreated adult malignant gliomas.
    J Neurooncol. 2019 Sep 9. pii: 10.1007/s11060-019-03285.
    PubMed     Text format     Abstract available

  18. EL-KHOULY FE, Veldhuijzen van Zanten SEM, Santa-Maria Lopez V, Hendrikse NH, et al
    Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?
    J Neurooncol. 2019 Sep 14. pii: 10.1007/s11060-019-03287.
    PubMed     Text format     Abstract available

  19. ZHAO SP, Wang F, Yang M, Wang XY, et al
    CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    J Neurooncol. 2019 Sep 9. pii: 10.1007/s11060-019-03286.
    PubMed     Text format     Abstract available

  20. HOU C, Ishi Y, Motegi H, Okamoto M, et al
    Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
    J Neurooncol. 2019 Sep 10. pii: 10.1007/s11060-019-03288.
    PubMed     Text format     Abstract available


    J Neuropathol Exp Neurol

  21. ZHANG H, Qin D, Jiang Z, Zhang J, et al
    SNHG9/miR-199a-5p/Wnt2 Axis Regulates Cell Growth and Aerobic Glycolysis in Glioblastoma.
    J Neuropathol Exp Neurol. 2019 Jul 23. pii: 5555858. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Nucl Med

  22. MAURER GD, Brucker DP, Stoffels G, Filipski K, et al
    (18)F-FET PET imaging in differentiating glioma progression from treatment-related changes - a single-center experience.
    J Nucl Med. 2019 Sep 13. pii: jnumed.119.234757. doi: 10.2967/jnumed.119.234757.
    PubMed     Text format     Abstract available


    Neuro Oncol

  23. JABARKHEEL R, Amayiri N, Yecies D, Huang Y, et al
    Molecular correlates of cerebellar mutism syndrome in medulloblastoma.
    Neuro Oncol. 2019 Aug 23. pii: 5554118. doi: 10.1093.
    PubMed     Text format     Abstract available

  24. LIM YC, Ensbey KS, Offenhauser C, D'Souza RCJ, et al
    Simultaneous Targeting of DNA Replication and Homologous Recombination in Glioblastoma with a Polyether Ionophore.
    Neuro Oncol. 2019 Aug 30. pii: 5556892. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. JIANG H, Yang K, Ren X, Cui Y, et al
    Diffuse midline glioma with an H3 K27M mutation: A comparison integrating the clinical, radiological, molecular features between adult and pediatric patients.
    Neuro Oncol. 2019 Aug 24. pii: 5554271. doi: 10.1093.
    PubMed     Text format     Abstract available

  26. ELLINGSON BM
    On the promise of artificial intelligence for standardizing radiographic response assessment in gliomas.
    Neuro Oncol. 2019 Sep 6. pii: 5561587. doi: 10.1093.
    PubMed     Text format    

  27. FOSTER JB, Madsen PJ, Hegde M, Ahmed N, et al
    Immunotherapy for pediatric brain tumors: past and present.
    Neuro Oncol. 2019 Aug 24. pii: 5554145. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. ZHANG S, Liao K, Miao Z, Wang Q, et al
    CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5.
    Neuro Oncol. 2019 Sep 4. pii: 5560150. doi: 10.1093.
    PubMed     Text format     Abstract available

  29. ECHIZENYA S, Ishii Y, Kitazawa S, Tanaka T, et al
    Discovery of a new pyrimidine synthesis inhibitor eradicating glioblastoma-initiating cells.
    Neuro Oncol. 2019 Sep 10. pii: 5566464. doi: 10.1093.
    PubMed     Text format     Abstract available

  30. WOLPERT F, Lareida A, Terziev R, Grossenbacher B, et al
    Risk factors for the development of epilepsy in patients with brain metastasis.
    Neuro Oncol. 2019 Sep 10. pii: 5566445. doi: 10.1093.
    PubMed     Text format     Abstract available

  31. GALLDIKS N, Verger A, Zaragori T, Unterrainer M, et al
    Comment on "Hypometabolic gliomas on FET-PET - Is there an inverted U-curve for survival?", Kamson 2019, Neuro-Oncology.
    Neuro Oncol. 2019 Sep 10. pii: 5567232. doi: 10.1093.
    PubMed     Text format    

  32. SURUN A, Varlet P, Brugieres L, Lacour B, et al
    Medulloblastomas associated with APC germline pathogenic variant share the good prognosis of CTNNB1 mutated medulloblastomas.
    Neuro Oncol. 2019 Aug 23. pii: 5554125. doi: 10.1093.
    PubMed     Text format     Abstract available

  33. WONG D, Yip S
    Finding a four-leaf clover - identifying long term survivors in IDH- wildtype glioblastoma.
    Neuro Oncol. 2019 Sep 12. pii: 5568014. doi: 10.1093.
    PubMed     Text format    

  34. MAJD N, Weathers SP, de Groot J
    Are we AKT-ually getting closer to making targeted therapy successful in breast cancer brain metastases?
    Neuro Oncol. 2019 Sep 13. pii: 5568470. doi: 10.1093.
    PubMed     Text format    


    Neurosurgery

  35. ZHONG J, Press RH, Olson JJ, Oyesiku NM, et al
    The use of Hypofractionated Radiosurgery for the Treatment of Intracranial Lesions Unsuitable for Single-Fraction Radiosurgery.
    Neurosurgery. 2018 Apr 28. pii: 4990001. doi: 10.1093.
    PubMed     Text format     Abstract available

  36. GILBRIDE L, Siker M, Bovi J, Gore E, et al
    Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review.
    Neurosurgery. 2018;82:595-603.
    PubMed     Text format     Abstract available

  37. CHESNEY K, Memel Z, Pangal DJ, Donoho D, et al
    Variability and Lack of Prognostic Value Associated With Atypical Pituitary Adenoma Diagnosis: A Systematic Review and Critical Assessment of the Diagnostic Criteria.
    Neurosurgery. 2017 Nov 18. doi: 10.1093.
    PubMed     Text format     Abstract available

  38. CHAO ST, De Salles A, Hayashi M, Levivier M, et al
    Stereotactic Radiosurgery in the Management of Limited (1-4) Brain Metasteses: Systematic Review and International Stereotactic Radiosurgery Society Practice Guideline.
    Neurosurgery. 2017 Nov 3. doi: 10.1093.
    PubMed     Text format     Abstract available

  39. GRAVBROT N, Kelly DF, Milligan J, Griffiths CF, et al
    The Minimal Clinically Important Difference of the Anterior Skull Base Nasal Inventory-12.
    Neurosurgery. 2017 Aug 4. doi: 10.1093.
    PubMed     Text format     Abstract available

  40. HIRSHMAN BR, Wilson BR, Ali MA, Schupper AJ, et al
    Cumulative Intracranial Tumor Volume Augments the Prognostic Value of Diagnosis-Specific Graded Prognostic Assessment Model for Survival in Patients with Melanoma Cerebral Metastases.
    Neurosurgery. 2017 Aug 4. doi: 10.1093.
    PubMed     Text format     Abstract available

  41. RAFFA G, Conti A, Scibilia A, Cardali SM, et al
    The Impact of Diffusion Tensor Imaging Fiber Tracking of the Corticospinal Tract Based on Navigated Transcranial Magnetic Stimulation on Surgery of Motor-Eloquent Brain Lesions.
    Neurosurgery. 2017 Nov 29. pii: 4675300. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS Genet

  42. PETRI R, Brattas PL, Sharma Y, Jonsson ME, et al
    LINE-2 transposable elements are a source of functional human microRNAs and target sites.
    PLoS Genet. 2019;15:e1008036.
    PubMed     Text format     Abstract available


    PLoS One

  43. SHIVRAM H, Le SV, Iyer VR
    PRC2 activates interferon-stimulated genes indirectly by repressing miRNAs in glioblastoma.
    PLoS One. 2019;14:e0222435.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: